Literature DB >> 20826293

Interpretation of the results of OVER in the context of EVAR trial, DREAM, and the EUROSTAR registry.

Mahmoud B Malas1, Julie A Freischlag.   

Abstract

Several early studies have shown the benefit of endovascular aneurysm repair in reducing procedure-related mortality and morbidity of open aneurysm repair. Three prospective randomized trials have addressed the advantages and disadvantages of the two procedures. These studies had shown some conflicting findings in survival and complications. We reviewed the largest registry for endovascular abdominal aortic repair and the three randomized trials to evaluate the similarities and differences in their outcomes. Cross-comparison of operative, aneurysm-related and all-cause mortality is presented. Patient characteristics, device specifications, procedure morbidity and reintervention rate of each study are evaluated. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20826293     DOI: 10.1053/j.semvascsurg.2010.05.009

Source DB:  PubMed          Journal:  Semin Vasc Surg        ISSN: 0895-7967            Impact factor:   1.000


  9 in total

1.  New Insights Into Aortic Diseases: A Report From the Third International Meeting on Aortic Diseases (IMAD3).

Authors:  Helena Kuivaniemi; Natzi Sakalihasan; Frank A Lederle; Gregory T Jones; Jean-Olivier Defraigne; Nicos Labropoulos; Victor Legrand; Jean-Baptiste Michel; Christoph Nienaber; Marc A Radermecker; John A Elefteriades
Journal:  Aorta (Stamford)       Date:  2013-06-01

2.  Safety of elective management of synchronous aortic disease with simultaneous thoracic and aortic stent graft placement.

Authors:  Salvatore T Scali; Robert J Feezor; Catherine K Chang; David H Stone; Philip P Goodney; Peter R Nelson; Thomas S Huber; Adam W Beck
Journal:  J Vasc Surg       Date:  2012-06-27       Impact factor: 4.268

Review 3.  Diagnostic and therapeutic strategies for small abdominal aortic aneurysms.

Authors:  Ahmed Klink; Fabien Hyafil; James Rudd; Peter Faries; Valentin Fuster; Ziad Mallat; Olivier Meilhac; Willem J M Mulder; Jean-Baptiste Michel; Francesco Ramirez; Gert Storm; Robert Thompson; Irene C Turnbull; Jesus Egido; Jose L Martín-Ventura; Carlos Zaragoza; Didier Letourneur; Zahi A Fayad
Journal:  Nat Rev Cardiol       Date:  2011-02-08       Impact factor: 32.419

4.  Preoperative prediction of mortality within 1 year after elective thoracic endovascular aortic aneurysm repair.

Authors:  Salvatore T Scali; Catherine K Chang; Robert J Feezor; Philip J Hess; Thomas M Beaver; Tomas D Martin; Thomas S Huber; Adam W Beck
Journal:  J Vasc Surg       Date:  2012-07-25       Impact factor: 4.268

5.  Ten-year results of endovascular abdominal aortic aneurysm repair from a large multicenter registry.

Authors:  Robert W Chang; Philip Goodney; Lue-Yen Tucker; Steven Okuhn; Hong Hua; Ann Rhoades; Nayan Sivamurthy; Bradley Hill
Journal:  J Vasc Surg       Date:  2013-05-14       Impact factor: 4.268

6.  Conservative management of chronic aortic dissection with underlying aortic aneurysm.

Authors:  Mohammad Yusuf Beebeejaun; Aleksandra Malec; Ravi Gupta; Hassan Alkhawam
Journal:  Heart Int       Date:  2013-03-15

7.  Five-year results of endovascular aortic repair used according to instructions for use give a good general outcome for abdominal aortic aneurysm.

Authors:  Runa G Unsgård; Martin Altreuther; Conrad Lange; Tommy Hammer; Erney Mattsson
Journal:  SAGE Open Med       Date:  2019-05-23

Review 8.  TEVAR and EVAR, the unknown knowns of the cardiovascular hemodynamics; and the immediate and long-term consequences of fabric material on major adverse clinical outcome.

Authors:  Sherif Sultan; Yogesh Acharya; Osama Soliman; Juan Carlos Parodi; Niamh Hynes
Journal:  Front Surg       Date:  2022-08-30

9.  Our early and mid-term results for endovascular repair of abdominal aortic aneurysms.

Authors:  Sedat Ozan Karakişi; Şaban Ergene; Doğuş Hemşinli; Şeref Alp Küçüker
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-01-01       Impact factor: 0.332

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.